Biohazards - EBOLA
EBOLA (chronology) is a member of the Filoviruses family in the Viral Hemorrhagic Fevers (VHFs) category. The latest outbreak of Ebola began March 2014 and continues but at a decreasing rate. CDC figures as of July 10, 2015 are:
Cases (suspected, probable and confirmed) 27,636
Laboratory Confirmed 15,159
Total Deaths 11,268
CDC has stated that symtoms may appear anywhere from 2 to 21 days after exposure to the Ebola virus though 8-10 days has been most common.
Mapp Biopharmaceuticals was among the first to respond with a new treatment. Little is published about Mapp which may indicate some military funding. Mapp developed experimental ZMAPP which has been given to Dr. Kent Brantly and Nancy Whiteboi - both have recovered. Other experimental drug treatments have been given other patients. It must be stressed that expermental drugs long term effectiveness, impact and side effects on a human are not established.
Can the Ebola virus be totally removed from recovered patients? One disturbing discovery...